Bioventus Inc Cl A (BVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Sales | 123,876 | 153,642 | 138,964 | 151,217 | 129,457 |
| Cost of Goods | 40,820 | 50,986 | 45,413 | 47,578 | 41,077 |
| Gross Profit | 83,056 | 102,656 | 93,551 | 103,639 | 88,380 |
| Operating Expenses | 79,007 | 95,939 | 90,317 | 135,690 | 83,529 |
| Operating Income | 4,869 | 7,703 | 3,647 | -31,473 | 4,928 |
| Interest Expense | 7,509 | 8,997 | 9,532 | 9,924 | 10,339 |
| Other Income | -777 | 1,241 | 626 | -159 | -63 |
| Pre-tax Income | -3,417 | -53 | -5,259 | -41,556 | -5,474 |
| Income Tax | -95 | 550 | 589 | -7,339 | 907 |
| Net Income Continuous | -3,322 | -603 | -5,848 | -34,217 | -6,381 |
| Minority Interests | -685 | -215 | -683 | -8,535 | -1,491 |
| Net Income | $-2,637 | $-388 | $-5,165 | $-25,682 | $-4,890 |
| EPS Basic Total Ops | -0.04 | 0.00 | -0.08 | -0.40 | -0.08 |
| EPS Basic Continuous Ops | -0.05 | 0.16 | -0.09 | -0.53 | -0.10 |
| EPS Diluted Total Ops | -0.04 | 0.00 | -0.08 | -0.40 | -0.08 |
| EPS Diluted Continuous Ops | -0.05 | 0.16 | -0.09 | -0.53 | -0.10 |
| EPS Diluted Before Non-Recurring Items | 0.08 | 0.15 | 0.06 | 0.19 | N/A |
| EBITDA(a) | $16,734 | $20,108 | $15,922 | $-18,383 | $16,713 |